These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19937685)

  • 1. Metformin, hepatitis C, and insulin resistance: sufficient evidence?
    Yilmaz Y; Yonal O; Imeryuz N
    Hepatology; 2009 Dec; 50(6):2054-5; author reply 2055. PubMed ID: 19937685
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin.
    Romero-Gómez M; Diago M; Andrade RJ; Calleja JL; Salmerón J; Fernández-Rodríguez CM; Solà R; García-Samaniego J; Herrerías JM; De la Mata M; Moreno-Otero R; Nuñez O; Olveira A; Durán S; Planas R;
    Hepatology; 2009 Dec; 50(6):1702-8. PubMed ID: 19845037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone as adjuvant therapy in chronic hepatitis C: sequential rather than concomitant administration with pegylated interferon and ribavirin?
    Serfaty L; Fartoux L; Poupon R
    J Hepatol; 2009 Jun; 50(6):1269-71. PubMed ID: 19395115
    [No Abstract]   [Full Text] [Related]  

  • 4. [Improved virologic response in chronic hepatitis C treated with peginterferon, ribavirin and add-on drug].
    Hokari A
    Nihon Rinsho; 2011 May; 69 Suppl 4():196-200. PubMed ID: 22096918
    [No Abstract]   [Full Text] [Related]  

  • 5. Pioglitazone in chronic hepatitis C not responding to pegylated interferon-alpha and ribavirin.
    Overbeck K; Genné D; Golay A; Negro F;
    J Hepatol; 2008 Aug; 49(2):295-8. PubMed ID: 18555553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance.
    Khattab M; Emad M; Abdelaleem A; Eslam M; Atef R; Shaker Y; Hamdy L
    Liver Int; 2010 Mar; 30(3):447-54. PubMed ID: 19919569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peginterferon alfa-2b plus ribavirin for chronic hepatitis.
    Cecil BD
    Lancet; 2002 Jan; 359(9302):263-4. PubMed ID: 11812598
    [No Abstract]   [Full Text] [Related]  

  • 8. Peginterferon alfa-2b plus ribavirin for chronic hepatitis.
    Picon PD; Costa AF; Kuchenbecker R; Beltrame A
    Lancet; 2002 Jan; 359(9302):263; author reply 264. PubMed ID: 11812597
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combination therapy of interferon plus ribavirin for chronic hepatitis C].
    Asahina Y; Izumi N
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):467-73. PubMed ID: 15359843
    [No Abstract]   [Full Text] [Related]  

  • 10. The substantial role of initial ribavirin dose on the response to peginterferon alpha/ribavirin therapy in patients with genotype 1b chronic hepatitis C.
    Dai CY; Huang CF; Chuang WL; Huang JF; Yu ML
    Am J Gastroenterol; 2009 Sep; 104(9):2358-9. PubMed ID: 19727098
    [No Abstract]   [Full Text] [Related]  

  • 11. [Patient, 50, with chronic hepatitis C genotype 1 infection. Therapeutic success despite poor prognosis].
    Klinker H
    MMW Fortschr Med; 2003 Oct; 145(41):39-40. PubMed ID: 14655480
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of PEG-interferon alfa-2a plus ribavirin as treatment for chronic HCV hepatitis in a child cured of ALL.
    Lo Nigro L; La Spina M; Mirabile E; Pisana P; Schilirò G; Guardo P
    Pediatr Blood Cancer; 2004 Aug; 43(2):185. PubMed ID: 15236293
    [No Abstract]   [Full Text] [Related]  

  • 13. Do differences in pegylation of interferon alfa matter?
    Zeuzem S
    Gastroenterology; 2010 Jan; 138(1):34-6. PubMed ID: 19932662
    [No Abstract]   [Full Text] [Related]  

  • 14. Tyranny of algorithms in the treatment of patients with hepatitis C.
    Rubin RA
    Hepatology; 2003 Dec; 38(6):1593-4; author reply 1594-5. PubMed ID: 14647072
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination treatment for chronic HCV hepatitis in lymphangioleiomyomatosis: first case report.
    Bartalesi F; Camiciottoli G; Corti G; Maluccio NM; Biliotti E; Bartoloni A; Taliani G
    J Chemother; 2009 Feb; 21(1):110-1. PubMed ID: 19297285
    [No Abstract]   [Full Text] [Related]  

  • 16. [Healing of chronic hepatitis C following 12 weeks of therapy with peginterferon-alpha and ribavirin].
    Barreales M; Castellano G; Fernández I; Muñoz R; Manzano M; Solís Herruzo JA
    Rev Esp Enferm Dig; 2007 Dec; 99(12):738-40. PubMed ID: 18290706
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis C treatment: interferon free or interferon freer?
    Dusheiko G; Burney T
    Lancet; 2013 Jun; 381(9883):2063-5. PubMed ID: 23499437
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatitis C: 15 years of life].
    Perez V
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S9-10. PubMed ID: 20214283
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic hepatitis C. First treatment].
    Colombato L; Descalzi V; Gadano A
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S37-9. PubMed ID: 20214297
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pegylated interferon alfa-2a. Improved prognosis in hepatitis C].
    MMW Fortschr Med; 2002 Sep; 144(38):59. PubMed ID: 12395712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.